Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.
about
Sympathetic nervous system regulation of the tumour microenvironmentPhosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTENA novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.Primary trastuzumab resistance: new tricks for an old drug.PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling.Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathwayPhosphorylation of the BNIP3 C-Terminus Inhibits Mitochondrial Damage and Cell Death without Blocking Autophagy.Molecular pathways: beta-adrenergic signaling in cancerExpression and clinicopathological significance of FSIP1 in breast cancer.Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and AnoikisCCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.Nervous system regulation of the cancer genome.A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancerLoss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.Array-based pharmacogenomics of molecular-targeted therapies in oncology.Advances in the approach to novel drug clinical development for breast cancer.FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.Molecular targets in glioblastoma.Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies.t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit.β2-AR signaling controls trastuzumab resistance-dependent pathway.Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.t-Darpp is an elongated monomer that binds calcium and is phosphorylated by cyclin-dependent kinases 1 and 5.Pathway-based discovery of genetic interactions in breast cancerTranscription factor CREB is phosphorylated in human molar odontoblasts and cementoblasts in vivo.PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.
P2860
Q26795614-9960B190-850B-49F1-A48B-6D188CD5EC95Q34324624-E2401ED6-827A-4AD6-B602-CFC42A07BA18Q34330451-03FAF16D-F284-4437-A1BE-5D5EA946C659Q34433064-26C5411A-CD5C-498E-8EC9-F33F084944C1Q34610251-45F9CC4F-DA4E-4269-811F-7D4DEDF310BDQ34664078-6F952F69-5C7F-4C47-A291-0E633B1760CAQ35067970-C0774D06-E78F-4966-8240-BB5F9B0D56EEQ35671780-5875646C-F7E1-4255-BF44-50DE80F0F46FQ35803280-64C7782E-A8BA-4AAF-BB30-C474C98615F9Q35833100-DBCAEB2E-4BC0-4CAA-9F83-0925969EE74BQ35957554-5F6F434C-07A5-44E6-A334-720DF952DD89Q36007881-910FFF89-32A6-48FC-B6EC-44C265102B56Q36692566-2E4C4D85-9B89-41DA-A8FC-0F5111DE0469Q37107395-338ED4AC-E884-4EBF-8E8A-37BCB030F6BFQ37708984-F4CE6D66-4914-441A-B094-34A202A28CABQ37976288-27E836F6-EBEA-43FE-961F-91A7CF8C9830Q38206546-982551F6-F5E6-4259-AA69-888A5272CD89Q38431717-4CF3913C-1B2E-48C5-99CB-19EC6FFF97DCQ38465854-C15002A6-1C6F-474C-ABF7-9F4B1AFB09B4Q38626744-94980A8B-CAA4-4E17-8577-74D7A2BE5FDFQ38693444-F1FFB536-8333-473B-A84E-1A076607662AQ38896403-6176BE8B-C8F4-4A99-A293-9A74C54D9556Q39686847-1E74B44A-8356-40E6-8C27-A64941110739Q41083994-3DC739A7-0A16-46B5-94DB-FE3FF62CAA98Q41627665-3D531EB4-A66F-425D-B6C7-1E3D03E3F1F6Q42366151-97695FF7-806E-44CE-BC27-6F0E7F97F6C7Q44626868-4E9858B8-FC92-443E-8513-4631D972EB00Q54466754-41106D60-D368-4466-B1CF-6BB35317B001
P2860
Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Protein kinase A activation co ...... uman breast cancer cell lines.
@en
Protein kinase A activation co ...... uman breast cancer cell lines.
@nl
type
label
Protein kinase A activation co ...... uman breast cancer cell lines.
@en
Protein kinase A activation co ...... uman breast cancer cell lines.
@nl
prefLabel
Protein kinase A activation co ...... uman breast cancer cell lines.
@en
Protein kinase A activation co ...... uman breast cancer cell lines.
@nl
P2093
P2860
P1476
Protein kinase A activation co ...... uman breast cancer cell lines.
@en
P2093
George Somlo
Sean K Lau
Sofia Loera
Susan E Kane
P2860
P304
P356
10.1158/1078-0432.CCR-09-0585
P407
P577
2009-11-17T00:00:00Z